Stay updated on Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has undergone significant content changes, including the removal of detailed information about a study evaluating cabozantinib for advanced hepatocellular carcinoma in Japanese patients, while retaining the study's title and some identifiers. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference44%
- Check68 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.